GlassScriptPhysician profile
Paul Bhella
NPI 1457538548
$193,911.76
in general payments reported to CMS, 2019-2025
15 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $55K · 2021: $20K · 2022: $21K · 2023: $25K · 2024: $20K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $6,802 · Food and Beverage: $2,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,400.00 |
| Travel and Lodging | $6,801.89 |
| Food and Beverage | $2,118.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $184,585.12 | 2019-2025 | Definity |
| Amgen INC. | $7,918.27 | 2022 | |
| Novartis Pharmaceuticals Corporation | $408.53 | 2023-2025 | Leqvio |
| Novo Nordisk INC | $183.05 | 2022-2024 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $169.37 | 2019-2023 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $135.97 | 2023 | Camzyos, Eliquis |
| Atricure, INC. | $130.72 | 2022 | |
| Getinge USA Sales, LLC | $121.14 | 2022 | |
| Pfizer INC. | $94.60 | 2022-2023 | |
| Abbott Laboratories | $67.69 | 2022-2024 | Jot Dx |
| Boston Scientific Corporation | $25.98 | 2024 | Latitude Communicator Power Supply |
| Kiniksa Pharmaceuticals International, Plc | $22.13 | 2024 | Arcalyst |
| Baxter Healthcare | $18.30 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $15.57 | 2022 | |
| Medtronic Vascular, INC. | $15.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Bhella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.